[780] NOVEL HEPARANASE INHIBITOR PI-88 EXTENDS DISEASE FREE SURVIVAL IN A RANDOMIZED PHASE II ADJUVANT CLINICAL TRIAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) AFTER CURATIVE RESECTION